Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/13885
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorMELLO, Roberta Ferreira de-
dc.contributor.authorSANTOS, Itamar de Souza-
dc.contributor.authorALENCAR, Airlane Pereira-
dc.contributor.authorBENSENOR, Isabela Martins-
dc.contributor.authorLOTUFO, Paulo Andrade-
dc.contributor.authorGOULART, Alessandra Carvalho-
dc.date.accessioned2016-07-04T13:52:04Z-
dc.date.available2016-07-04T13:52:04Z-
dc.date.issued2016-
dc.identifier.citationJOURNAL OF STROKE & CEREBROVASCULAR DISEASES, v.25, n.3, p.618-625, 2016-
dc.identifier.issn1052-3057-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/13885-
dc.description.abstractBackground: The influence of poststroke depression on long-term survival is poorly investigated. Thus, we aimed to evaluate the influence of major depression disorder (MDD) on long-term survival in the participants from The Study of Stroke Mortality and Morbidity in Adults (EMMA Study) in Sao Paulo, Brazil. Methods: We prospectively evaluated ischemic and hemorrhagic stroke (HS) cases from the EMMA Study. Baseline and stroke characteristics and cardiovascular risk factors were evaluated according to MDD assessed by the Patient Health Questionnaire, which was applied 30 days after index event and periodically during 1-year followup. We performed Kaplan-Meier survival analysis, as well as crude and multiple Cox proportional hazards models. Results: In this subset of the EMMA Study, we evaluated 164 (85.9%) patients with ischemic stroke and 27 (14.1%) with HS. Among these, overall incidence of MDD was 25.1% during 1 year of follow-up, regardless stroke subtype. The peak rate of major depression postacute event was beyond 1 month. We observed a lower survival rate among individuals who developed poststroke MDD than among those who did not develop this condition after 1 year of follow-up (85.4% versus 96.5%, log rank P = .006). After multiple analysis, we kept a higher risk of all-cause mortality among those who developed MDD compared to participants without MDD (hazard ratio = 4.60, 95% confidence interval = 1.36-15.55, P = .01). Conclusion: Our findings suggest that incident MDD is a potential marker of poor prognosis 1 year after stroke.-
dc.language.isoeng-
dc.publisherELSEVIER SCIENCE BV-
dc.relation.ispartofJournal of Stroke & Cerebrovascular Diseases-
dc.rightsrestrictedAccess-
dc.subjectStroke-
dc.subjectdepression-
dc.subjectsurvival-
dc.subjectmortality-
dc.subjectepidemiology-
dc.subjectcohort-
dc.subject.otherpoststroke depression-
dc.subject.otherlesion location-
dc.subject.othermood disorders-
dc.subject.othermental-health-
dc.subject.otherphq-9-
dc.subject.othersurveillance-
dc.subject.othersymptoms-
dc.subject.otherrisk-
dc.subject.othercare-
dc.subject.othermetaanalysis-
dc.titleMajor Depression as a Predictor of Poor Long-Term Survival in a Brazilian Stroke Cohort (Study of Stroke Mortality and Morbidity in Adults) EMMA study-
dc.typearticle-
dc.rights.holderCopyright ELSEVIER SCIENCE BV-
dc.identifier.doi10.1016/j.jstrokecerebrovasdis.2015.11.021-
dc.identifier.pmid26725125-
dc.subject.wosNeurosciences-
dc.subject.wosPeripheral Vascular Disease-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.author.externalALENCAR, Airlane Pereira:Univ Sao Paulo, Inst Math & Stat, BR-05508000 Sao Paulo, Brazil-
hcfmusp.description.beginpage618-
hcfmusp.description.endpage625-
hcfmusp.description.issue3-
hcfmusp.description.volume25-
hcfmusp.origemWOS-
hcfmusp.origem.id2-s2.0-84959495701-
hcfmusp.origem.idWOS:000371175900024-
hcfmusp.publisher.cityAMSTERDAM-
hcfmusp.publisher.countryNETHERLANDS-
hcfmusp.relation.referenceVataja R, 2004, J NEUROPSYCH CLIN N, V16, P156, DOI 10.1176/appi.neuropsych.16.2.156-
hcfmusp.relation.referenceTruelsen T, 2001, INT J EPIDEMIOL, V30, pS11-
hcfmusp.relation.referenceSims J, 2009, INT J GERIATR PSYCH, V24, P76, DOI 10.1002/gps.2082-
hcfmusp.relation.referenceLowe B, 2004, J AFFECT DISORDERS, V81, P61, DOI 10.1016/S0165-0327(03)00198-8-
hcfmusp.relation.referenceHackett ML, 2005, STROKE, V36, P2296, DOI 10.1161/01.STR.0000183622.75135.a4-
hcfmusp.relation.referenceJohnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7-
hcfmusp.relation.referenceBhogal SK, 2004, STROKE, V35, P794, DOI 10.1161/01.STR.0000117237.98749.26-
hcfmusp.relation.referenceToso V, 2004, NEUROL SCI, V25, P138, DOI 10.1007/s10072-004-0247-y-
hcfmusp.relation.referenceBerg A, 2003, STROKE, V34, P138, DOI 10.1161/01.STR.0000048149.84268.07-
hcfmusp.relation.referenceWilliams LS, 2005, STROKE, V36, P635, DOI 10.1161/01.STR.0000155688.18207.33-
hcfmusp.relation.referenceAyerbe L, 2011, STROKE, V42, P1907, DOI 10.1161/STROKEAHA.110.605808-
hcfmusp.relation.referenceROBINSON RG, 1984, BRAIN, V107, P81, DOI 10.1093/brain/107.1.81-
hcfmusp.relation.referenceKroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x-
hcfmusp.relation.referenceTerroni L, 2011, WORLD J BIOL PSYCHIA, V12, P539, DOI 10.3109/15622975.2011.562242-
hcfmusp.relation.referenceLotufo PA, 2013, INT J STROKE, V8, P155, DOI 10.1111/j.1747-4949.2011.00757.x-
hcfmusp.relation.referenceGoulart AC, 2010, INT J STROKE, V5, P284, DOI 10.1111/j.1747-4949.2010.00441.x-
hcfmusp.relation.referenceHackett ML, 2005, STROKE, V36, P1330, DOI 10.1161/01.STR.0000165928.19135.35-
hcfmusp.relation.referenceHackett ML, 2014, INT J STROKE, V9, P1017, DOI 10.1111/ijs.12357-
hcfmusp.relation.referenceVataja R, 2001, ARCH GEN PSYCHIAT, V58, P925, DOI 10.1001/archpsyc.58.10.925-
hcfmusp.relation.referenceKessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095-
hcfmusp.relation.referenceKaton WJ, 2003, BIOL PSYCHIAT, V54, P216, DOI 10.1016/S0006-3223(03)00273-7-
hcfmusp.relation.referenceHouse A, 2001, STROKE, V32, P696-
hcfmusp.relation.referenceHankey GJ, 2002, STROKE, V33, P1034, DOI 10.1161/01.STR.0000012515.66889.24-
hcfmusp.relation.referencePaolucci S, 2005, ACTA PSYCHIAT SCAND, V112, P272, DOI 10.1111/j.1600-0447.2005.00590.x-
hcfmusp.relation.referenceGilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y-
hcfmusp.relation.referenceEllis C, 2010, J PSYCHOSOM RES, V68, P545, DOI 10.1016/j.jpsychores.2009.11.006-
hcfmusp.relation.referenceAyerbe L, 2014, J NEUROL NEUROSUR PS, V85, P514, DOI 10.1136/jnnp-2013-306448-
hcfmusp.relation.referenceASTROM M, 1993, STROKE, V24, P976-
hcfmusp.relation.referenceLotufo PA, 2007, LANCET NEUROL, V6, P387, DOI 10.1016/S1474-4422(07)70091-1-
hcfmusp.relation.referenceMORRIS PLP, 1993, AM J PSYCHIAT, V150, P124-
hcfmusp.relation.referenceKauhanen ML, 1999, STROKE, V30, P1875-
hcfmusp.relation.referenceJoubert J, 2008, CEREBROVASC DIS, V26, P199, DOI 10.1159/000145328-
hcfmusp.relation.referenceKing RB, 1996, STROKE, V27, P1467-
hcfmusp.relation.referenceCarod-Artal FJ, 2009, J NEUROL SCI, V284, P63, DOI 10.1016/j.jns.2009.04.008-
hcfmusp.relation.referenceSchulz R, 2000, ARCH INTERN MED, V160, P1761, DOI 10.1001/archinte.160.12.1761-
hcfmusp.relation.referenceROBINSON RG, 1983, STROKE, V14, P736-
hcfmusp.relation.reference[Anonymous], 1988, AM J PSYCHIAT-
hcfmusp.relation.referenceYusuf S, 2014, NEW ENGL J MED, V371, P818, DOI 10.1056/NEJMoa1311890-
hcfmusp.relation.referenceGoulart AC, 2012, J STROKE CEREBROVASC, V21, P832, DOI 10.1016/j.jstrokecerebrovasdis.2011.04.017-
hcfmusp.relation.referenceRamasubbu R, 2003, CAN J PSYCHIAT, V48, P250-
hcfmusp.relation.referenceFernandes TG, 2012, CAD SAUDE PUBLICA, V28, P1581, DOI 10.1590/S0102-311X2012000800016-
hcfmusp.relation.referenceOsorio FD, 2009, PERSPECT PSYCHIATR C, V45, P216-
hcfmusp.relation.referenceBartoli F, 2013, STROKE RES TREAT, V2013, DOI [DOI 10.1155/2013/862978, 10.1155/2013/862978]-
hcfmusp.relation.referenceBonita R, 2002, SURVEILLANCE STROKE-
hcfmusp.relation.referenceGoulart AC, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-51-
hcfmusp.relation.referenceHaq Sophia Ul, 2010, Psychiatr Danub, V22 Suppl 1, pS33-
hcfmusp.relation.referenceHERMANN N, 1998, STROKE, V29, P618-
hcfmusp.relation.referenceKhan Maria, 2012, BMC Res Notes, V5, P89, DOI 10.1186/1756-0500-5-89-
hcfmusp.relation.referenceLotufo Paulo Andrade, 2005, Sao Paulo Med J, V123, P3, DOI 10.1590/S1516-31802005000100001-
hcfmusp.relation.referencePaolucci Stefano, 2008, Neuropsychiatr Dis Treat, V4, P145-
hcfmusp.relation.referencePaul N, 2013, AM J GERIAT PSYCHIAT, V21, P821, DOI 10.1016/j.jagp.2013.03.013-
hcfmusp.relation.referencePfeil Michael, 2009, Br J Nurs, V18, P365-
hcfmusp.relation.referencePhelan E, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-63-
hcfmusp.relation.referenceWilliams LS, 2004, AM J PSYCHIAT, V161, P1090, DOI 10.1176/appi.ajp.161.6.1090-
hcfmusp.relation.referenceWorld Health O, 2006, WHO STEPS STROK MAN-
hcfmusp.relation.referenceZhang WN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078981-
dc.description.indexMEDLINE-
dc.identifier.eissn1532-8511-
hcfmusp.citation.scopus26-
hcfmusp.scopus.lastupdate2024-04-12-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MCM
Departamento de Clínica Médica - FM/MCM

Artigos e Materiais de Revistas Científicas - HU
Hospital Universitário - HU

Artigos e Materiais de Revistas Científicas - LIM/20
LIM/20 - Laboratório de Terapêutica Experimental

Artigos e Materiais de Revistas Científicas - LIM/51
LIM/51 - Laboratório de Emergências Clínicas

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar


Files in This Item:
File Description SizeFormat 
art_MELLO_Major_Depression_as_a_Predictor_of_Poor_LongTerm_2016.PDF
  Restricted Access
publishedVersion (English)284.48 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.